Integration of innate immune signalling by caspase-8 cleavage of N4BP1.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
11 2020
Historique:
received: 08 04 2020
accepted: 17 09 2020
pubmed: 25 9 2020
medline: 12 2 2021
entrez: 24 9 2020
Statut: ppublish

Résumé

Mutations in the death receptor FAS

Identifiants

pubmed: 32971525
doi: 10.1038/s41586-020-2796-5
pii: 10.1038/s41586-020-2796-5
doi:

Substances chimiques

Adaptor Proteins, Vesicular Transport 0
Cytokines 0
N4BP1 protein, human 0
Nuclear Proteins 0
RNA-Binding Proteins 0
TICAM1 protein, human 0
TLR3 protein, human 0
TLR4 protein, human 0
Toll-Like Receptor 3 0
Toll-Like Receptor 4 0
Tumor Necrosis Factor-alpha 0
Caspase 8 EC 3.4.22.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

275-280

Commentaires et corrections

Type : CommentIn

Références

Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347–1349 (1995).
pubmed: 7539157 doi: 10.1126/science.7539157
Fisher, G. H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935–946 (1995).
pubmed: 7540117 doi: 10.1016/0092-8674(95)90013-6
Del-Rey, M. et al. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. Blood 108, 1306–1312 (2006).
pubmed: 16627752 doi: 10.1182/blood-2006-04-015776
Chun, H. J. et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419, 395–399 (2002).
pubmed: 12353035 doi: 10.1038/nature01063
Lehle, A. S. et al. Intestinal inflammation and dysregulated immunity in patients with inherited caspase-8 deficiency. Gastroenterology 156, 275–278 (2019).
pubmed: 30267714 doi: 10.1053/j.gastro.2018.09.041
Bolze, A. et al. Whole-exome-sequencing-based discovery of human FADD deficiency. Am. J. Hum. Genet. 87, 873–881 (2010).
pubmed: 21109225 pmcid: 2997374 doi: 10.1016/j.ajhg.2010.10.028
Peterson, L. W. et al. Cell-extrinsic TNF collaborates with TRIF signaling to promote Yersinia-induced apoptosis. J. Immunol. 197, 4110–4117 (2016).
pubmed: 27733552 doi: 10.4049/jimmunol.1601294
Weng, D. et al. Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death. Proc. Natl Acad. Sci. USA 111, 7391–7396 (2014).
pubmed: 24799678 doi: 10.1073/pnas.1403477111 pmcid: 4034196
Kang, S. et al. Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat. Commun. 6, 7515 (2015).
pubmed: 26104484 doi: 10.1038/ncomms8515
Mandal, P. et al. Caspase-8 collaborates with caspase-11 to drive tissue damage and execution of endotoxic shock. Immunity 49, 42–55.e6 (2018).
pubmed: 30021146 pmcid: 6064639 doi: 10.1016/j.immuni.2018.06.011
Philip, N. H. et al. Activity of uncleaved caspase-8 controls anti-bacterial immune defense and TLR-induced cytokine production independent of cell death. PLoS Pathog. 12, e1005910 (2016).
pubmed: 27737018 pmcid: 5063320 doi: 10.1371/journal.ppat.1005910
DeLaney, A. A. et al. Caspase-8 promotes c-Rel-dependent inflammatory cytokine expression and resistance against Toxoplasma gondii. Proc. Natl Acad. Sci. USA 116, 11926–11935 (2019).
pubmed: 31147458 doi: 10.1073/pnas.1820529116 pmcid: 6575527
Allam, R. et al. Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non-apoptotic caspase-8 is required for inflammasome priming. EMBO Rep. 15, 982–990 (2014).
pubmed: 24990442 pmcid: 4198042 doi: 10.15252/embr.201438463
Varfolomeev, E. E. et al. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267–276 (1998).
pubmed: 9729047 doi: 10.1016/S1074-7613(00)80609-3
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. & Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314–317 (1992).
pubmed: 1372394 doi: 10.1038/356314a0
Günther, C. et al. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature 477, 335–339 (2011).
pubmed: 21921917 pmcid: 3373730 doi: 10.1038/nature10400
Welz, P. S. et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477, 330–334 (2011).
pubmed: 21804564 doi: 10.1038/nature10273
Wu, J. et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 23, 994–1006 (2013).
pubmed: 23835476 pmcid: 3731568 doi: 10.1038/cr.2013.91
He, S., Liang, Y., Shao, F. & Wang, X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl Acad. Sci. USA 108, 20054–20059 (2011).
pubmed: 22123964 doi: 10.1073/pnas.1116302108 pmcid: 3250173
Kaiser, W. J. et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J. Biol. Chem. 288, 31268–31279 (2013).
doi: 10.1074/jbc.M113.462341
Pham, V. C. et al. Complementary proteomic tools for the dissection of apoptotic proteolysis events. J. Proteome Res. 11, 2947–2954 (2012).
pubmed: 22432722 doi: 10.1021/pr300035k
Rush, J. et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23, 94–101 (2005).
pubmed: 15592455 doi: 10.1038/nbt1046
Kumar, S., van Raam, B. J., Salvesen, G. S. & Cieplak, P. Caspase cleavage sites in the human proteome: CaspDB, a database of predicted substrates. PLoS ONE 9, e110539 (2014).
pubmed: 25330111 pmcid: 4201543 doi: 10.1371/journal.pone.0110539
Zhang, H. et al. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471, 373–376 (2011).
pubmed: 21368761 pmcid: 3072026 doi: 10.1038/nature09878
Oberst, A. et al. Catalytic activity of the caspase-8–FLIP
pubmed: 21368763 pmcid: 3077893 doi: 10.1038/nature09852
Kaiser, W. J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368–372 (2011).
pubmed: 21368762 pmcid: 3060292 doi: 10.1038/nature09857
Dillon, C. P. et al. Survival function of the FADD–CASPASE-8–cFLIP
pubmed: 22675671 pmcid: 3366463 doi: 10.1016/j.celrep.2012.03.010
Newton, K. et al. Activity of caspase-8 determines plasticity between cell death pathways. Nature 575, 679–682 (2019).
pubmed: 31723262 doi: 10.1038/s41586-019-1752-8
Yamasoba, D. et al. N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation. Nat. Microbiol. 4, 1532–1544 (2019).
pubmed: 31133753 doi: 10.1038/s41564-019-0460-3
Heger, K. et al. OTULIN limits cell death and inflammation by deubiquitinating LUBAC. Nature 559, 120–124 (2018).
pubmed: 29950720 doi: 10.1038/s41586-018-0256-2
Oh, S. A., Seki, A. & Rutz, S. Ribonucleoprotein transfection for CRISPR/Cas9-mediated gene knockout in primary T cells. Curr. Protoc. Immunol. 124, e69 (2019).
pubmed: 30334617 doi: 10.1002/cpim.69
Nepravishta, R. et al. CoCUN, a novel ubiquitin binding domain identified in N4BP1. Biomolecules 9, 284 (2019).
pmcid: 6681339 doi: 10.3390/biom9070284
Zhang, X. et al. An interaction landscape of ubiquitin signaling. Mol. Cell 65, 941–955 (2017).
pubmed: 28190767 doi: 10.1016/j.molcel.2017.01.004
Fenner, B. J., Scannell, M. & Prehn, J. H. M. Identification of polyubiquitin binding proteins involved in NF-κB signaling using protein arrays. Biochim. Biophys. Acta 1794, 1010–1016 (2009).
pubmed: 19285159 doi: 10.1016/j.bbapap.2009.02.013
Deguine, J., Wei, J., Barbalat, R., Gronert, K. & Barton, G. M. Local TNFR1 signaling licenses murine neutrophils for increased TLR-dependent cytokine and eicosanoid production. J. Immunol. 198, 2865–2875 (2017).
pubmed: 28219890 doi: 10.4049/jimmunol.1601465
Singh, J. A. et al. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet 386, 258–265 (2015).
pubmed: 25975452 pmcid: 4580232 doi: 10.1016/S0140-6736(14)61704-9
van der Poll, T., Keogh, C. V., Buurman, W. A. & Lowry, S. F. Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice. Am. J. Respir. Crit. Care Med. 155, 603–608 (1997).
pubmed: 9032201 doi: 10.1164/ajrccm.155.2.9032201
Murphy, J. M. et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39, 443–453 (2013).
pubmed: 24012422 doi: 10.1016/j.immuni.2013.06.018
Newton, K., Sun, X. & Dixit, V. M. Kinase RIP3 is dispensable for normal NF-κBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell. Biol. 24, 1464–1469 (2004).
pubmed: 14749364 pmcid: 344190
Newton, K. et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343, 1357–1360 (2014).
doi: 10.1126/science.1249361 pubmed: 24557836
Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640–643 (2003).
pubmed: 12855817 doi: 10.1126/science.1087262
Peschon, J. J. et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160, 943–952 (1998).
pubmed: 9551933
Newton, K. et al. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. Nature 574, 428–431 (2019).
pubmed: 31511692 doi: 10.1038/s41586-019-1548-x
Ryder, E. et al. Rapid conversion of EUCOMM/KOMP-CSD alleles in mouse embryos using a cell-permeable Cre recombinase. Transgenic Res. 23, 177–185 (2014).
pubmed: 24197666 doi: 10.1007/s11248-013-9764-x
Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827–832 (2013).
pubmed: 23873081 pmcid: 3969858 doi: 10.1038/nbt.2647
Hindson, B. J. et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem. 83, 8604–8610 (2011).
pubmed: 22035192 pmcid: 3216358 doi: 10.1021/ac202028g
Freund, E. C. et al. Efficient gene knockout in primary human and murine myeloid cells by non-viral delivery of CRISPR-Cas9. J. Exp. Med. 217, e20191692 (2020).
pubmed: 32357367 pmcid: 7336301 doi: 10.1084/jem.20191692
Wu, T. D. & Watanabe, C. K. GMAP: a genomic mapping and alignment program for mRNA and EST sequences. Bioinformatics 21, 1859–1875 (2005).
pubmed: 15728110 doi: 10.1093/bioinformatics/bti310
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792 pmcid: 4402510 doi: 10.1093/nar/gkv007
Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).
pubmed: 30944313 pmcid: 6447622 doi: 10.1038/s41467-019-09234-6
Turner, M. D., Nedjai, B., Hurst, T. & Pennington, D. J. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim. Biophys. Acta 1843, 2563–2582 (2014).
pubmed: 24892271 doi: 10.1016/j.bbamcr.2014.05.014
Elias, J. E. & Gygi, S. P. Target-decoy search strategy for mass spectrometry-based proteomics. Methods Mol. Biol. 604, 55–71 (2010).
pubmed: 20013364 pmcid: 2922680 doi: 10.1007/978-1-60761-444-9_5
Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N. & Sternberg, M. J. E. The Phyre2 web portal for protein modeling, prediction and analysis. Nat. Protocols 10, 845–858 (2015).
pubmed: 25950237 doi: 10.1038/nprot.2015.053

Auteurs

Alexander D Gitlin (AD)

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. adgitlin@stanford.edu.
Department of Physiological Chemistry, Genentech, South San Francisco, CA, USA. adgitlin@stanford.edu.

Klaus Heger (K)

Department of Physiological Chemistry, Genentech, South San Francisco, CA, USA.

Alexander F Schubert (AF)

Department of Structural Biology, Genentech, South San Francisco, CA, USA.

Rohit Reja (R)

Department of Bioinformatics and Computational Biology, Genentech, South San Francisco, CA, USA.

Donghong Yan (D)

Department of Translational Immunology, Genentech, South San Francisco, CA, USA.

Victoria C Pham (VC)

Department of Microchemistry, Proteomics and Lipidomics, Genentech, South San Francisco, CA, USA.

Eric Suto (E)

Department of Translational Immunology, Genentech, South San Francisco, CA, USA.

Juan Zhang (J)

Department of Translational Immunology, Genentech, South San Francisco, CA, USA.

Youngsu C Kwon (YC)

Department of Translational Immunology, Genentech, South San Francisco, CA, USA.

Emily C Freund (EC)

Department of Molecular Biology, Genentech, South San Francisco, CA, USA.

Jing Kang (J)

Department of Translational Immunology, Genentech, South San Francisco, CA, USA.

Anna Pham (A)

Department of Molecular Biology, Genentech, South San Francisco, CA, USA.

Roger Caothien (R)

Department of Molecular Biology, Genentech, South San Francisco, CA, USA.

Natasha Bacarro (N)

Department of Molecular Biology, Genentech, South San Francisco, CA, USA.

Trent Hinkle (T)

Department of Microchemistry, Proteomics and Lipidomics, Genentech, South San Francisco, CA, USA.

Min Xu (M)

Department of Translational Immunology, Genentech, South San Francisco, CA, USA.

Brent S McKenzie (BS)

Department of Translational Immunology, Genentech, South San Francisco, CA, USA.

Benjamin Haley (B)

Department of Molecular Biology, Genentech, South San Francisco, CA, USA.

Wyne P Lee (WP)

Department of Translational Immunology, Genentech, South San Francisco, CA, USA.

Jennie R Lill (JR)

Department of Microchemistry, Proteomics and Lipidomics, Genentech, South San Francisco, CA, USA.

Merone Roose-Girma (M)

Department of Molecular Biology, Genentech, South San Francisco, CA, USA.

Monika Dohse (M)

Department of Pathology, Genentech, South San Francisco, CA, USA.

Joshua D Webster (JD)

Department of Pathology, Genentech, South San Francisco, CA, USA.

Kim Newton (K)

Department of Physiological Chemistry, Genentech, South San Francisco, CA, USA. knewton@gene.com.

Vishva M Dixit (VM)

Department of Physiological Chemistry, Genentech, South San Francisco, CA, USA. dixit@gene.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH